Inogen, Inc. provided revenue guidance for the year 2023. For the full year, the company now expects 2023 annual revenue of $315 million to $320 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.3 USD | +2.47% | -5.79% | +51.18% |
05-15 | Inogen, Inc. Announces Separation of Stanislav Glezer as Executive Vice President, R&D and Chief Medical Officer | CI |
05-07 | Transcript : Inogen, Inc., Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.18% | 196M | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+9.25% | 42.5B | |
+15.97% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- INGN Stock
- News Inogen, Inc.
- Inogen, Inc. Provides Revenue Guidance for the Year 2023